Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer

Noronha, V; Patil, VM; Joshi, A; Menon, N; Chougule, A; Mahajan, A; Janu, A; Purandare, N; Kumar, R; More, S; Goud, S; Kadam, N; Daware, N; Bhattacharjee, A; Shah, S; Yadav, A; Trivedi, V; Behel, V; Dutt, A; Banavali, SD; Prabhash, K

Prabhash, K (corresponding author), Homi Bhabha Natl Inst, Tata Mem Ctr, Dept Med Oncol, Mumbai, Maharashtra, India.

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (2): 124

Abstract

PURPOSE Standard first-line therapy for EGFR-mutant advanced non-small-cell lung cancer (NSCLC) is an epidermal growth factor receptor (EGFR)-directed......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索